Scandium Canada increases bought deal to $15-million

Executive Summary

• Scandium Canada Ltd. has amended its previously announced bought deal offering to increase the total size to $15 million in aggregate gross proceeds.
• The offering consists of 68,182,000 units priced at $0.22 per unit, with each unit comprising one common share and one common share purchase warrant.
• Proceeds are designated for project expenditures at the Crater Lake project, development of proprietary Al-Sc alloys, and general corporate working capital.

Key Details

• Offering Size: Increased to $15,000,040 in aggregate gross proceeds.
• Units Sold: 68,182,000 units.
• Price Per Unit: $0.22.
• Underwriter: Research Capital Corp. (RCC) acting as lead underwriter and sole bookrunner.
• Unit Composition: Each unit consists of one common share and one common share purchase warrant.
• Warrant Terms (Investor): Each warrant entitles the holder to acquire one common share at an exercise price of $0.30 per share for a period of 30 months from the closing date.
• Over-Allotment Option: Underwriters have an option to purchase up to an additional 10,227,300 units on the same terms, generating up to $2,250,006 in additional gross proceeds.
• Use of Proceeds:
  1. Project expenditures and works on the Crater Lake project.
  2. Development and precommercialization work on proprietary Al-Sc (aluminum-scandium) alloys.
  3. General corporate and working capital purposes.
• Closing Date: Expected on or about March 17, 2026, subject to closing conditions including TSX Venture Exchange approval.
• Underwriter Compensation:
  • Cash commission of up to 6% of aggregate gross proceeds (including option exercise).
  • Non-transferable warrants equal to up to 6% of the number of units sold (including option exercise).
  • Broker Warrant Terms: Exercise price of $0.22 per share, exercisable for 30 months following closing, subject to a statutory hold period of four months and one day.
• Regulatory Basis: Issued in reliance on the listed issuer financing exemption under National Instrument 45-106 (Part 5A) for Canadian residents (excluding Quebec) and Regulation 45-106 for Quebec residents.

Notable Quotes

• None provided in the text.